“Although the company has not made the technical details of the process to the public, citing proprietary concerns, 3DBio says that federal regulations have already reviewed the trial and the data would be published in a peer-reviewed medical journal upon its completion.”
3DBio Therapeutics grew a patient’s own ear cartilage cells, printed them into an ear and grafted it on. About 1,500 Americans are born with microtia each year, and the current fix carves cartilage out of their ribcage. The trial has 11 patients and the results arrived by press release. The “first-ever success” comes with no published data and a promise to share later.